Back
Kala Bio Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
35
KALA
Kala Bio
Last Price:
6.74
Seasonality Move:
-31.53%
Buy
60
PLX
Protalix BioTherapeutics
Last Price:
1.14
Seasonality Move:
0.94%
Sell
35
Kala Bio (KALA)
is a Sell
Is Kala Bio a Buy, Sell or Hold?
- The current Kala Bio [KALA] share price is $6.87. The Score for KALA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KALA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.16. The Score for PLX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KALA Stock Price Chart
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
KALA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 47.97 | Sell |
| Chaikin Money Flow: | -1180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.53 - 7.09) | Buy |
| Bollinger Bands (100): | (6.8 - 7.76) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 47.63 | Sell |
| Chaikin Money Flow: | 296039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.13 - 1.21) | Sell |
| Bollinger Bands (100): | (1.2 - 1.62) | Sell |
KALA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.93 | Sell |
| 20-day SMA: | 6.73 | Buy |
| 50-day SMA: | 7.27 | Sell |
| 200-day SMA: | 8.35 | Sell |
| 8-day EMA: | 6.86 | Buy |
| 20-day EMA: | 6.9 | Sell |
| 50-day EMA: | 7.09 | Sell |
| 200-day EMA: | 9.18 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Buy |
| 20-day SMA: | 1.16 | Sell |
| 50-day SMA: | 1.25 | Sell |
| 200-day SMA: | 1.53 | Sell |
| 8-day EMA: | 1.15 | Buy |
| 20-day EMA: | 1.17 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 1.49 | Sell |
Kala Bio Earnings Growth & KALA Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.59 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.31 per share, and a decrease next year of $0.00 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kala Bio Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||